TRAVOPROST 0.004% EYE DROP

What it is

TRAVOPROST 0.004% EYE DROP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “travoprost”, “travoprost (isomer free)”, “travoprost ophthalmic solution” and “travoprost ophthalmic solution, 0.004%”, as its NDCs’ listings variously write the nonproprietary name, under the trade names “Travoprost Ophthalmic” and “Travoprost Ophthalmic Soluton”.

FDA gives its dosage form as “solution/ drops” and “solution” and its route as ophthalmic.

FDA lists 6 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., Sagent Pharmaceuticals and Micro Labs Limited.

FDA’s Established Pharmacologic Class for it is Prostaglandin Analog.

The NADAC file of 2026-10-14 prices it under 12 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $8.39 – $9.75 for 1 mL, depending on the NDC ($8.39412 to $9.74746 per ML), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

What NADAC measures · NADAC explanation codes

The 6 labelers

Other strengths, forms and brands

1 other product in the NADAC file shares an FDA nonproprietary name with TRAVOPROST 0.004% EYE DROP.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 12 NDCs’ NADAC prices is $8.39412 per ML filed.

Of the 6 other products in FDA’s Prostaglandin Analog class priced per ML, 5 have a higher middle NADAC price and 1 a lower one. The one in the middle is LATISSE 0.03% EYELASH SOLUTION, at $31.49063 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $30.77 for 1 mL, at an average of $30.77339 per ML in 2024 (2024-01-01 to 2024-12-31) for “Travoprost”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 476,526 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 1 mL? Is it lower than what I would pay through my insurance?
• Which NDC (the 11-digit number on the package) is this? Pharmacies pay $8.39412 to $9.74746 per ML for this product, depending on the NDC.
• How much is in the package I am getting? This page uses 1 mL; your package may hold a different amount.
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.